VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

<< Previous

Bullboard Posts

Next >>

Post by Pandoraon Jul 31, 2024 7:34pm

142 Views

Post# 36157300

News re Patent Application for a Probe

It seems the patent application for the new probe has hit a roadblock with the U.S. patent office again.

A "probe" appears to be next to impossible to get clearance because of what it is i.e. there must be hundreds of probes out there. This rejection is again referred to as a "non-final rejection". The info sent back to the inventor includes 19 pages of "prior art" i.e. other probes that have been submitted and approved and now the VPT inventor must explain how his invention is different from all these others.
It's a herculean task and takes a whole lot of time.